Clinical trial NCT04379349: Using Short Message Service as a Means of Clinical Engagement in Early Psychosis
Official title: Using Short Message Service as a Means of Clinical Engagement in Early Psychosis
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Psychotic Disorders
Keywords: SMS text messaging
Clinical engagement
Lead sponsor: Centre for Addiction and Mental Health
Sponsor class: OTHER
First posted: 2020-05-07
Enrollment: 61
Sex: ALL
Minimum age (years): 16
Maximum age (years): 29
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Engagement with clinical services for youth with early psychosis represents a significant challenge, with up to 40% of patients dropping out of treatment in the first year. This has been linked to worse illness outcomes and represents a significant barrier to recovery for these patients. This study aims to evaluate the efficacy of short message service (SMS) as a means of improving clinical engagement in early-episode psychosis populations by bridging contact between appointments with weekly check-ins/reminders. These weekly check-ins during the first year of treatment will serve as an additional opportunity to reach out to patients and give them a chance to do the same with their care teams, with patient responses triggering clinician follow-up if necessary.


Eligibility criteria: Inclusion Criteria:

* between the ages of 16-29
* a diagnosis of an affective or non-affective psychotic disorder (i.e., Bipolar or Major Depressive Disorders with Psychotic Features, Schizophrenia Spectrum Disorders, Other Specified Psychotic Disorders, Substance Induced Psychosis and Attenuated Psychotic Syndrome)
* eligible for follow-up within the Slaight Family Centre for Youth in Transition early intervention service
* within the first 6 months of treatment

Exclusion Criteria:

* involved in another intervention study
* do not have a personal cell phone number

Primary outcomes:
measure: Service Engagement Scale (SES)
timeFrame: 9 months
measure: Appointment Attendance
timeFrame: 9 months
Secondary outcomes:
measure: Emergency Department Visits
timeFrame: 9 months
measure: Hospitalizations
timeFrame: 9 months
measure: Social Functioning Scale (SFS)
timeFrame: 9 months
measure: Personal and Social Performance Scale (PSP)
timeFrame: 9 months
measure: Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LESQ-18)
timeFrame: 9 months
measure: Clinical Global Impression (CGI)
timeFrame: 9 months
measure: Brief Psychiatric Rating Scale (BPRS)
timeFrame: 9 months
measure: Scale for the Assessment of Negative Symptoms (SANS)
timeFrame: 9 months
measure: Apathy Evaluation Scale (AES)
timeFrame: 9 months
measure: Brief Cognitive Assessment Tool for Schizophrenia (B-CATS)
timeFrame: 9 months
measure: Drug Attitude Inventory (DAI-10)
timeFrame: 9 months
measure: Scale To Assess Therapeutic Relationships - Patient Version (STAR-P)
timeFrame: 9 months
Other outcomes:
Locations:
city: Toronto
country: Canada
facility: Centre for Addiction and Mental Health
state: Ontario
Study officials:
affiliation: Centre for Addiction and Mental Health
name: George Foussias, MD PhD
role: PRINCIPAL_INVESTIGATOR
References: